Scientists identify new role for tau protein in brain diseases
On Sept. 8, 2026, researchers from the National Institutes of Health (NIH) found that hyperphosphorylated tau activates reverse…
On Sept. 8, 2026, researchers from the National Institutes of Health (NIH) found that hyperphosphorylated tau activates reverse…
On Sept. 8, 2026, Google DeepMind released the AlphaGenome Atlas: a platform containing predictions for the effects of…
On Sept. 1, 2026, Vertex Pharmaceuticals announced the successful completion of the acquisition of Crinetics Pharmaceuticals, a global…
On Aug. 27, 2026, Roivant announced that the U.S. Food and Drug Administration (FDA) has approved LISRAYA™ (brepocitinib)…
On Aug. 25, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported that In 2024, the…
On Aug. 20, 2026, Genentech, a member of the Roche Group, announced plans to invest approximately $750 million…
On Aug. 12, 2026, the Medical Research Council (MRC) announced a £20 million investment in a new Pre-clinical…
On Aug. 10, 2026, Jazz Pharmaceuticals and Actio Biosciences announced the companies have entered into a definitive agreement…
On Aug. 3, 2026, Michigan, state health officials announced that two people have died in the cyclospora outbreak,…
On Aug. 3, 2026, UCLA researchers announced they have grown brain cells from dozens of genetically distinct donors…
On Jul. 27, 2026, Michigan health officials reported 9,253 cases of cyclosporiasis, an increase of 1,077 cases since…
On Jul. 27, 2026, argenx, a global immunology innovation company, and Dallas-based Forte Biosciences announced that the companies…
On Jul. 24, 2026, Merck announced it has signed seven voluntary licensing agreements with generic drug manufacturers to…
On Jul. 14, 2026, the Centers for Disease Control and Prevention announced it is notifying clinicians, public health…
On Jul. 13, 2026, a team led by bioengineers at the University of California San Diego has developed…
On Jul. 13, 2026, Eisai Co. and Biogen announced that the U.S. Food and Drug Administration (FDA) has…
On Jul. 13, 2026, In a study published in Nature Communications, Saurja DasGupta, a biochemist at the University…
On Jul. 10, 2026, The NYC Health Department released, for the first time, a preliminary list of 31…
On Jul. 7, 2026, the U.S. Food and Drug Administration has approved Vera Therapeutics’ drug to treat patients…
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
On Jul. 1, 2026, Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic…
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
On Jun. 26, 2026, Chronic diabetic wounds heal slowly and are highly vulnerable to infection. Researchers report developing…
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
On Jun. 23, 2026 – researchers from the Pacific Northwest Research Institute in Seattle announced they have identified…
On Jun. 22, 2026, Louisiana’s first Sickle Cell Disease gene therapy patient is now set to pursue his…
On Jun. 17, 2026, a team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences…
On Jun. 11, 2026, the University of Oklahoma (OU) announced it had received an $11.5 million award from…
On Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor…
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…